|
OSBPL11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.10959999971772E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.038400E-04 |
| Normal-vs-Stage2 |
2.097700E-03 |
| Normal-vs-Stage3 |
3.281700E-02 |
| Normal-vs-Stage4 |
2.980600E-01 |
| Stage1-vs-Stage2 |
4.470800E-01 |
| Stage1-vs-Stage3 |
4.382400E-01 |
| Stage1-vs-Stage4 |
2.775200E-03 |
| Stage2-vs-Stage3 |
7.598200E-01 |
| Stage2-vs-Stage4 |
5.920900E-03 |
| Stage3-vs-Stage4 |
1.788400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.79799999964348E-07 |
| Normal-vs-AfricanAmerican |
6.900300E-03 |
| Normal-vs-Asian |
9.740600E-01 |
| Caucasian-vs-AfricanAmerican |
9.638400E-01 |
| Caucasian-vs-Asian |
2.765200E-01 |
| AfricanAmerican-vs-Asian |
3.552800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.19199999554831E-08 |
| Normal-vs-Female |
3.716400E-03 |
| Male-vs-Female |
4.654800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.355360E-01 |
| Normal-vs-Extreme_Weight |
4.243000E-03 |
| Normal-vs-Obese |
2.617800E-04 |
| Normal-vs-Extreme_Obese |
3.211200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.852400E-01 |
| Normal_Weight-vs-Obese |
2.764200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.316200E-01 |
| Extreme_Weight-vs-Obese |
1.869760E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.197600E-01 |
| Obese-vs-Extreme_Obese |
4.079000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.215040E-01 |
| Normal-vs-Age(41-60Yrs) |
1.37379999998188E-06 |
| Normal-vs-Age(61-80Yrs) |
2.176300E-04 |
| Normal-vs-Age(81-100Yrs) |
1.011780E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.662200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.992600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.363800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.063990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.300200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.374200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.00700000005283E-06 |
| Normal-VS-Type2 PRCC |
1.896580E-03 |
| Normal-VS-KIRP CIMP |
7.261400E-01 |
| Normal-VS-Unclassified PRCC |
1.162790E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.841800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.858590E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.176400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.764200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.290400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.995500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.465790E-02 |
| Normal-vs-N1 |
5.655900E-02 |
| Normal-vs-N2 |
4.818100E-02 |
| N0-vs-N1 |
3.230600E-01 |
| N0-vs-N2 |
1.133180E-01 |
| N1-vs-N2 |
2.283600E-01 |
|
|
